Clinical Trial Update: A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 safety trial evaluating MVA-BN Filo and Ad26.ZEBOV vaccines in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease
• Marburg Virus Disease

Drugs mentioned

• Ad26.ZEBOV
• MVA-BN-Filo

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Ebola Disease, Marburg Disease | Phase 1 | Status: COMPLETED